Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pulmo-Dose, Inc. is a specialty pharmacy and pharmaceutical distribution company that operates as a wholly-owned subsidiary of Rotech Healthcare Inc. Based in Murray, Kentucky, the company specializes in providing inhalation medications and respiratory therapy products to patients across the United States. Pulmo-Dose is known for its compounding services, where it prepares customized formulations of respiratory drugs such as albuterol, budesonide, and ipratropium for use in nebulizers. The company plays a critical role in Rotech's home respiratory care business, serving as a centralized pharmacy for mail-order delivery of nebulized medications. In 2024, Owens & Minor announced plans to acquire Rotech (including Pulmo-Dose) for $1.36 billion, but the deal was terminated in June 2025 due to regulatory hurdles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pulmo-Dose.